Violaine Planté‐Bordeneuve

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

50h-index14.1kcitations219works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes(172), Parathyroid Disorders and Treatments(48), Cellular transport and secretion(23), Peptidase Inhibition and Analysis(23), Protein Kinase Regulation and GTPase Signaling(22)

Publications216 total

A case of acute myelopathy in ATTR-Val30Met amyloidosis with leptomeningeal involvement: pathophysiological insights and upcoming therapeutic challenges
Amyloid·2025
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS
Cardiology and Therapy·2025· 1 citedOpen Access
Kidney Outcomes in Patients With Hereditary Transthyretin Amyloid Nephropathy Treated With Transthyretin Stabilizers And Gene-Silencer Therapies
Kidney International Reports·2025· 2 citedOpen Access
Complete remission after patisiran treatment in a patient with nephrotic syndrome secondary to hereditary transthyretin amyloidosis (ATTR)
Amyloid·2025
Neuropatie amiloidi ereditarie
EMC - Neurologia·2025Open Access
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
JAMA Neurology·2025· 20 citedOpen Access
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
Figshare·2025Open Access
Phenotype and Prognostic Factors in Geriatric and Non-Geriatric Patients with Transthyretin Cardiomyopathy
ESC Heart Failure·2024· 3 citedOpen Access
Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy
European Journal of Neurology·2024· 7 citedOpen Access
Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy
Expert Opinion on Drug Discovery·2024· 15 citedOpen Access
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
PLoS ONE·2024· 8 citedOpen Access
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
Cardiology and Therapy·2023· 18 citedOpen Access
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Orphanet Journal of Rare Diseases·2023· 52 citedOpen Access
Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca
Orphanet Journal of Rare Diseases·2023· 3 citedOpen Access
Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France
Archives of cardiovascular diseases·2023· 17 cited
Study of the parent-of-origin effect in monogenic diseases with variable age of onset. Application on ATTRv
PLoS ONE·2023· 2 citedOpen Access
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay
Amyloid·2023· 13 citedOpen Access
Prévalence et caractéristiques des polyradiculoneuropathies démyélinisantes associées au Brentuximab-Vedotin. Une étude de cohorte rétrospective
Revue Neurologique·2023
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis
Amyloid·2023· 7 cited
Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study
Nephrology Dialysis Transplantation·2023· 7 cited
page 1 of 11Next →

Frequent Co-authors

Teresa Coelho(18), David Adams(14), Márcia Waddington‐Cruz(14), Thibaud Damy(12), Hartmut Schmidt(11), Isabel Conceição(11), John L. Berk(10), Ole B. Suhr(10), Arnt V. Kristen(9), Michael Polydefkis(9), Giampaolo Merlini(9), Claudio Rapezzi(8), Mathew S. Maurer(8), Aziz Guellich(7), Giuseppe Vita(6), Yoshiki Sekijima(6), P. James B. Dyck(6), Brian Drachman(6), Angela Dispenzieri(6), Jean‐Luc Dubois‐Randé(6)